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blood vessel samples was performed.
RESULTS Hypertensive subjects with VC had higher serum OPN and
OPG levels compared to these without VC, and their expressions
were also increased in the calciﬁc vessels (P <0.05). Interestingly, the
inﬂammatory factors from hypertensive patients with VC were
signiﬁcantly increased in cultured macrophages (P <0.05), and were
regulated by OPN and OPG.
CONCLUSIONS These ﬁndings provided a novel insight that OPN and
OPG-mediated inﬂammatory factors expression in macrophages were
involved in the processes of VC in hypertensive patients.
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OBJECTIVES Multiple unbiased genome-wide wide association studies
have identiﬁedastrong linkbetween9p21.3 locus andatheroscleroticdisease
risk. However, the direct mechanism accounting for the 9p21.3 CAD (Coro-
nary Artery Disease) risk still remains poorly understood and controversial.
Previous work including ours demonstrated that altered expression INK4/
ARF locus by non-coding RNA ANRILmight contribute to the 9p21.3 genetic
atherosclerosis susceptibility. Studies from other groups also suggested
possible physical interaction among 9p21.3, INK4/ARF locus and type I IFN
gene cluster. However, recent study has showed that 9p21 locus does not
affect risk of coronary artery disease through direct induction of type I IFNs.
METHODS To investigate whether type I IFN is co-regulated with
INK4/ARF and contributes to clinical onset of CAD in Han Chinese, we
ﬁrst examined the relationship of IFN subtypes with 9p21.3 variants in
170 healthy individuals in US, followed by plasma IFNa21 measure-
ment in 300 Han Chinese with CAD of different severity.
RESULTS We found that mRNA expression of IFNa21 correlated with
the expression of ARF and cANRIL, as well as rs10757278 CAD risk
allele. The expression of IFNa21 did not correlate with CAD severity
quantiﬁed by coronary angiography but was associated with the age of
CAD onset in Han Chinese.
CONCLUSIONS These data suggest that type I IFNs does not
contribute to CAD severity but may play a role in the age of onset of
CAD, possibly through an ANRIL-mediated co-regulatory mechanism
with INK4/ARF locus.
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OBJECTIVES The aim of this study was to combine clinical criteria
and next-generation sequencing (pyrosequencing) to establish a
diagnosis of familial hypercholesterolemia (FH).
METHODS A total of 39 subjects with a Dutch Lipid Clinic Network
score of 8 (deﬁnite FH clinical diagnosis) were recruited from the
Lipid Clinic at Anzhen Hospital, Beijing, China. Next-generation
sequencing was performed in all subjects using a GenCap Custom
Enrichment Kit (MyGenostics, Beijing, China), a kit that detects in 167
disease genes, relevant with blood lipids and cholic acid metabolism,
including low-density lipoprotein receptor (LDLR), apolipoprotein B
(APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9) 3
known FH-causing genes.
RESULTS A total of 24 mutations were detected in 39 subjects.
Amongst these, 19 mutations were in the LDLR gene, three in the
APOB gene and two in the PCSK9 gene. We also found 151 SNPs and 69
genes relevant with blood lipids. Of these, 40 high frequency SNPs
and top 10 genes were summarized. The fourth, a mutation in LDLR
has not previously been reported; it was found to segregate with high
cholesterol levels in the family of the proband.
CONCLUSIONS Using a combination of clinical criteria and targeted
exome sequencing, we have achieved FH diagnosis with a high success
rate. Furthermore, we identiﬁed a new mutation in the LDLR gene.GW26-e2955
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OBJECTIVES Our previous study showed that decreased GPx-1 ac-
tivity in KD patients was associated with the GPx-1 Pro198Leu poly-
morphism and Se deﬁciency. The purpose of this study is to further
elucidate the association between different Se levels and the
GPx-1P198L.
METHODS GPx-1P198L transgenic mice (Tg) were generated and fed by
control diet (CON, 0.1-0.2mg Se/kg) or Se-deﬁcient diet (SD, <0.02 mg
Se/kg) for 12 weeks. Heart GPX-1 expression was detected by realtime
RT-PCR and western blot. Echocardiographic measurements were
performed to measure the cardiac function. Serum Se was analyzed by
a ﬂameless atomic absorption spectrophotometry method. Myocardial
GPx activity was spectrophotometrically measured using a cellular
glutathione peroxidase activity assay kit. Caspase-9 and 3 levels were
detected by western blot.
RESULTS In GPx-1P198L transgenic mice, heart GPx-1 expression was
remarkable upregulated when compared with wide type (WT) control
(P<0.05), whereas, GPx-1 activity showed no difference (P>0.05). Se
deﬁciency resulted in cardiac systolic dysfunction both in WT and Tg
mice and showed no difference (P>0.05). Se deﬁciency led to
myocardial ﬁbrosis accompanied by increased expression of caspase-9
and -3 In WT mice. But in Tg mice, expression levels of caspase-9 and
-3 were attenuated, whereas, myocardial ﬁbrosis was not signiﬁcantly
decreased.
CONCLUSIONS Overexpression of GPx-1P198L did not show evident
protection against cardiac remodeling and failure. These results
further documented that GPx-1P198L might be a functional poly-
morphism which may cause functional deﬁciency of GPx-1.GW26-e3821
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OBJECTIVES Ischemic postcontioning (IPoC) is an effective method
to prevent myocardial ischemia reperfusion injury (MIRI), but its
cardioprotection is usually blocked in the presence of hypercholes-
terolemia (HC) and the potential mechanism is still unknown.
METHODS In this study, we investigated the roles of reperfusion
injury salvage kinase (RISK) and apoptosis-related pathways in the
attenuation of cardioprotection of IPoC in the presence of HC.
RESULTS The results showed that IPoC signiﬁcantly decreased the
infarct size and apoptosis, improved the recovery of ischemic
myocardium, but these beneﬁcial effects were reversed by high
cholesterol diet-induced HC. Moreover, we also found that HC
inhibited the phosphorylation of Akt and ERK1/2 which usually acti-
vated by IPoC in normal heart, induced excessive apoptosis by down-
regulating Bcl-2 and up-regulating Bax, cytochrome c, caspase 9 and
caspase 3 when compared with that in normal heart.
CONCLUSIONS Taken together, our results demonstrated that the
cardioprotection of IPoC was abolished by HC, which was associated
with inactivation of RISK signal pathway and dysregulation of
downstream apoptosis-related pathway.
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OBJECTIVES Brugada syndrome (BrS) is a clinical entity with high
incidence of sudden cardiac death. Diagnosis of BrS solely relies on
